First human tests begin for potential diabetes treatment
NCT ID NCT07270731
Summary
This early-stage study is testing the safety and body's response to a new injectable medicine called NNC9733-0001 for type 2 diabetes. It involves 72 participants, including both healthy volunteers and people with type 2 diabetes, who receive either the medicine or a placebo injection. The main goal is to see how safe the medicine is and how the body processes it over about 10 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Profil Institut für Stoffwechselforschung GmbH
RECRUITINGNeuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.